Henry Cheng

Henry Cheng is an accomplished professional in health economics and research with extensive experience in both the pharmaceutical and fitness industries. Currently, Henry serves as Senior Director of Health Economics & Outcomes Research at Neurocrine Biosciences. Henry has held significant roles including Associate Director of Global Health Economics & Outcomes Research at Ultragenyx Pharmaceutical Inc. and Medical Affairs Manager at Inflammatix, Inc. Additionally, Henry has contributed to group fitness as a substitute instructor for high-intensity cardio and kickboxing classes at the YMCA of Silicon Valley, alongside prior experience as a fitness instructor at 24 Hour Fitness. Educational credentials include a PhD in Bioengineering and a Master of Arts in Public Policy from Stanford University, as well as a Bachelor of Science in Biological Engineering from the University of Hawaii at Manoa. Henry’s research background includes work on metagenomic sequencing and public policy related to pandemic preparedness, reflecting a strong interdisciplinary expertise.